CORRIGENDUM: Safety and Efficacy Re-Evaluation of Edoxaban and Rivaroxaban Dosing With Plasma Concentration Monitoring in Non-Valvular Atrial Fibrillation: With Observations of On-Label and Off-Label Dosing
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
[This corrects the article DOI: 10.1253/circrep.CR-22-0076.].